Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.

Details

Language :

English

ISSN :

14492288

Volume :

18

Issue :

1

Database :

Complementary Index

Journal :

International Journal of Biological Sciences

Publication Type :

Academic Journal

Accession number :

177048624

Full Text :

https://doi.org/10.7150/ijbs.64167